Search Results - "Forner, Alejandro"

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International.

Authors: Aghemo, Alessio Forner, Alejandro Valenti, Luca

Source: Liver International. May2023, Vol. 43 Issue 5, p956-957. 2p.

Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study.

Authors: Muñoz‐Martínez, Sergio Sapena, Victor Forner, Alejandro et al.

Source: Liver International. Aug2022, Vol. 42 Issue 8, p1891-1901. 11p. 5 Charts, 1 Graph.

Advancing radiology reporting with large language models: Is GPT- 4 the LI- RADS game changer or just a wild card?

Authors: Díaz González, Álvaro Forner, Alejandro Turnes, Juan

Source: Liver International. Jul2024, Vol. 44 Issue 7, p1575-1577. 3p.

Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients.

Authors: Saborido, Belén Darnell, Anna Forner, Alejandro et al.

Source: European Radiology. Sep2025, Vol. 35 Issue 9, p5771-5780. 10p.

Subjects: Contrast-enhanced ultrasound, Hepatocellular carcinoma, Liver tumors, Diagnostic examinations, Noninvasive diagnostic tests, Cirrhosis of the liver, Magnetic resonance imaging

Measuring the impact of the updated Steatotic liver disease nomenclature and definition.

Authors: Valenti, Luca Aghemo, Alessio Forner, Alejandro et al.

Source: Liver International. Nov2023, Vol. 43 Issue 11, p2340-2342. 3p.

Dolutegravir-based Antiretroviral Therapy in People With HIV With Solid Organ Transplantation: A Single-arm Pilot Clinical Trial (DTG-SOT).

Authors: Miro, Jose M Malano-Barletta, Daniela Berrocal, Leire et al.

Source: Open Forum Infectious Diseases. Apr2025, Vol. 12 Issue 4, p1-9. 9p.

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk.

Authors: Granel, Núria Iserte, Gemma Bartres, Concepció et al.

Source: BMC Gastroenterology. 2/3/2025, Vol. 25 Issue 1, p1-10. 10p.

Barcelona Clinic Liver Cancer 2022 update: Linking prognosis prediction and evidence‐based treatment recommendation with multidisciplinary clinical decision‐making.

Authors: Mauro, Ezequiel Forner, Alejandro

Source: Liver International. Mar2022, Vol. 42 Issue 3, p488-491. 4p. 1 Diagram.

Adherence and quality are key for a beneficial HCC surveillance.

Authors: Da Fonseca, Leonardo G. Forner, Alejandro

Source: Liver International. Apr2020, Vol. 40 Issue 4, p751-753. 3p. 1 Diagram.

Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Authors: Rimola, Jordi Forner, Alejandro Sapena, Víctor et al.

Source: European Radiology. Jan2020, Vol. 30 Issue 1, p186-194. 9p. 3 Diagrams, 4 Charts.

Subjects: Diffusion magnetic resonance imaging, Early diagnosis, Hepatitis C virus, Salvage therapy, Informed consent (Medical law)

Non-invasive diagnostic criteria for hepatocellular carcinoma: The value of contrast washout at imaging and the death of alpha-fetoprotein.

Authors: Forner, Alejandro Raoul, Jean-Luc

Source: Liver International. Nov2011, Vol. 31 Issue 10, p1419-1421. 3p.

Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.

Authors: Ayuso, Carmen Forner, Alejandro Darnell, Anna et al.

Source: Liver International. Jul2019, Vol. 39 Issue 7, p1281-1291. 11p. 4 Diagrams, 4 Charts.

Hepatobiliary contrast agents in MR: Where we stand and future perspectives.

Authors: Rimola, Jordi Forner, Alejandro

Source: Liver International. May2021, Vol. 41 Issue 5, p888-890. 3p. 1 Chart.

The tireless search to improve the prognostic assessment of intrahepatic cholangiocarcinoma: An urgent need.

Authors: Muñoz‐Martínez, Sergio Forner, Alejandro

Source: Liver International. Feb2021, Vol. 41 Issue 2, p252-254. 3p. 1 Chart.

New Scenarios in Liver Transplantation for Hepatocellular Carcinoma.

Authors: Mauro, Ezequiel Rodríguez‐Perálvarez, Manuel D'Alessio, Antonio et al.

Source: Liver International. Apr2025, Vol. 45 Issue 4, p1-16. 16p.

Immunotherapy in biliary tract cancer: The race has begun!

Authors: Mauro, Ezequiel Forner, Alejandro

Source: Liver International. Aug2023, Vol. 43 Issue 8, p1620-1622. 3p. 1 Chart.

Utilizing a domain-specific large language model for LI-RADS v2018 categorization of free-text MRI reports: a feasibility study.

Authors: Matute-González, Mario Darnell, Anna Comas-Cufí, Marc et al.

Source: Insights into Imaging. 11/22/2024, Vol. 15 Issue 1, p1-11. 11p.

Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies.

Authors: Mauro, Ezequiel Sanduzzi-Zamparelli, Marco Jutras, Gabrielle et al.

Source: Cancers. Sep2024, Vol. 16 Issue 17, p3059. 19p.

Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies.

Authors: Ros-Buxó, Mar Mauro, Ezequiel Sauri, Tamara et al.

Source: Current Oncology. Jul2024, Vol. 31 Issue 7, p3615-3629. 15p.

Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis.

Authors: Mauro, Ezequiel Sanduzzi-Zamparelli, Marco Sauri, Tamara et al.

Source: Cancers. Jun2024, Vol. 16 Issue 11, p2077. 12p.